Indian pharma companies get almost 70% of the active pharmaceutical ingredients (APIs) for their medicines from China. Already, the coronavirus outbreak has disrupted businesses dependent on Chinese supplies and industry professionals
Read full Post
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment